Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
Search
Filter
Clear All341-360 of 659 results
-
-
Out-Of-Pocket Costs Put HIV Prevention Drug Out Of Reach For Many At Risk
It’s getting increasingly difficult for patients to afford Truvada, also known as pre-exposure prophylaxis, or PrEP, because of the drug’s high price and insurance company efforts to restrict the use of coupons that shield patients from it.
By Shefali Luthra and Anna Gorman -
California Governor’s Bill-Signing Marathon Offers Glimpse Of 2020 Issues
California Gov. Gavin Newsom signed off on an array of health care bills that will significantly affect the lives of Californians, including many college students, pregnant women, schoolchildren and dialysis patients.
-
Federally Funded Obria Prescribes Abstinence To Stop The Spread Of STDs
Obria, a Christian medical chain, was awarded federal family planning funds for its California clinics for the first time this year. Clinics receiving Title X funds are expected to treat and prevent sexually transmitted diseases. Obria’s prohibition against condoms means its prevention efforts rest on abstinence, even as STD rates surge.
By Sarah Varney -
Border Fight: Trump’s Plan To Import Cheaper Drugs From Canada Faces Hurdles
The administration’s proposed rule to allow states to bring in prescription medications isn’t expected to provide immediate relief.
-
Sen. Orrin Hatch’s Legacy Tracks the GOP’s Evolution on Health
The man who forged a successful working relationship with Democratic health giants, such as Sen. Edward Kennedy and Rep. Henry Waxman, fell back on his deep conservative roots as opposition grew to the Affordable Care Act and the administration of President Barack Obama.
By Julie Rovner -
California Attempts To Revive Compassionate Cannabis Programs
After the state legalized recreational marijuana in 2016, new taxes and regulations decimated an ad hoc network that had donated cannabis for medical purposes to patients who could not afford it. A recent law seeks to revive the network, but hurdles remain.
-
Team Trump Says Administration’s Action On Health Care ‘Is Working.’ Is It?
The impact of the Trump administration’s health policies is not as clear-cut as the president’s reelection campaign suggests.
-
Congenital Syphilis Continues to Rise at an Alarming Rate
The number of U.S. infants who acquired syphilis from their mothers during pregnancy rose 40% last year. Just five states, including California, accounted for nearly two-thirds of the cases.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
-
PrEP Campaign Aims To Block HIV Infection And Save Lives In D.C.
Washington, D.C., is trying to stop new cases of HIV in the district by making sure residents who might be at risk are taking PrEP, medicine that cuts the risk of contracting the virus by 92 percent.
-
Florida Is The Latest Republican-Led State To Adopt Clean Needle Exchanges
Florida has struggled for years with opioid overdoses — and the highest rate of HIV infection in the U.S. Lawmakers now hope needle exchanges and a "harm reduction" approach could help save lives.
-
Former California State Contractor Sued Over Breach Of HIV Patient Privacy
A lawsuit claims that a private company hired by the state public health department to manage enrollment in an AIDS drug assistance program for low-income patients inadvertently allowed unauthorized access to their medical status.
By Anna Gorman -
Think ‘Medicare For All’ Is The Only Democratic Health Plan? Think Again
The Democratic presidential candidates have hit hard on health care, but generally the debates have centered on what kind of system candidates propose. The candidates’ ideas on many other issues, such as mental health and gun safety, have attracted much less attention.
-
Use Of HIV-Prevention Drug Grows, But Lags Among Non-Whites
The pill, known as PrEP, can reduce the risk of contracting the virus that causes AIDS by 90 percent. Its use has expanded sharply in recent years — but primarily among a white demographic.
By Anna Gorman -
Needle Exchanges Find New Champions Among Republicans
More Republicans, at the statehouse level, are saying research and results support their endorsement of a once-controversial plan to limit disease among drug users.
-
FAQ: How Does New Trump Fetal Tissue Policy Impact Medical Research?
The scientific use of tissue from aborted fetuses has frequently been a hot point of contention between anti-abortion forces and researchers. It heats up again as federal officials announced this week they were ending NIH research using the tissue.
-
Despite Failed Promises, Stem Cell Advocates Again Want Taxpayers To Pony Up Billions
California’s stem cell agency, created by a $3 billion bond measure 15 years ago, is almost out of money. Its supporters plan to ask voters for even more funding next year, even though no agency-funded treatments have been approved for widespread use.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
-
Trump Administration ‘Open For Business’ On Drug Imports From Canada
HHS secretary announces a preliminary plan Wednesday to allow Americans to import certain lower-cost drugs from Canada. Manufacturers were quick to criticize the plan, saying it does not guarantee the safety of drugs coming into the country.